| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |